子宮筋腫治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Uterine Fibroids Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C6057
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、104ページ
• 納品方法：Eメール
• 産業分類：Medical Care

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、子宮筋腫治療の世界市場について調べ、まとめました。種類別セグメントは、子宮内膜アブレーション、MRIガイド下手技、子宮摘出、筋腫摘出、子宮動脈塞栓術、高周波アブレーション、その他等、用途別セグメントは、等に区分しました。子宮筋腫治療の世界市場概観、企業動向、企業別子宮筋腫治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・子宮筋腫治療の市場概観
・子宮筋腫治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・子宮筋腫治療の企業別販売動向、市場シェア、市場集中度、競争動向
・子宮筋腫治療の世界市場規模
・子宮筋腫治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・子宮筋腫治療のアメリカ市場規模推移
・子宮筋腫治療のカナダ市場規模推移
・子宮筋腫治療のメキシコ市場規模推移
・子宮筋腫治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・子宮筋腫治療のドイツ市場規模推移
・子宮筋腫治療のイギリス市場規模推移
・子宮筋腫治療のロシア市場規模推移
・子宮筋腫治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・子宮筋腫治療の日本市場規模推移
・子宮筋腫治療の中国市場規模推移
・子宮筋腫治療の韓国市場規模推移
・子宮筋腫治療のインド市場規模推移
・子宮筋腫治療の東南アジア市場規模推移
・子宮筋腫治療の南米市場分析（ブラジル、アルゼンチン等）
・子宮筋腫治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・子宮筋腫治療の種類別分析/販売量、売上、市場シェア（子宮内膜アブレーション、MRIガイド下手技、子宮摘出、筋腫摘出、子宮動脈塞栓術、高周波アブレーション、その他）
・子宮筋腫治療の用途別分析/市場規模（）
・子宮筋腫治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・子宮筋腫治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Uterine Fibroids Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Uterine Fibroids Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Uterine Fibroids Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Uterine Fibroids Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
LiNA Medical
Merit Medical Systems
Cooper Surgical
Richard Wolf Medical Instruments
Blue Endo
Boston Scientific Corporation
Richard Wolf GmbH
Karl Storz
Halt Medical, Inc.
Olympus Corporation
Halt Medical, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others

Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others

レポート目次

Table of Contents

1 Uterine Fibroids Treatment Market Overview
1.1 Product Overview and Scope of Uterine Fibroids Treatment
1.2 Classification of Uterine Fibroids Treatment by Types
1.2.1 Global Uterine Fibroids Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Uterine Fibroids Treatment Revenue Market Share by Types in 2018
1.2.3 Endometrial Ablation
1.2.4 MRI Guided Procedures
1.2.5 Hysterectomy
1.2.6 Myomectomy
1.2.7 Uterine Artery Embolization
1.2.8 Radiofrequency Ablation
1.2.9 Others
1.3 Global Uterine Fibroids Treatment Market by Application
1.3.1 Global Uterine Fibroids Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Uterine Fibroids Treatment Market by Regions
1.4.1 Global Uterine Fibroids Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Uterine Fibroids Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Uterine Fibroids Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Uterine Fibroids Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Uterine Fibroids Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Uterine Fibroids Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Uterine Fibroids Treatment (2014-2024)
2 Company Profiles
2.1 LiNA Medical
2.1.1 Business Overview
2.1.2 Uterine Fibroids Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 LiNA Medical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merit Medical Systems
2.2.1 Business Overview
2.2.2 Uterine Fibroids Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merit Medical Systems Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cooper Surgical
2.3.1 Business Overview
2.3.2 Uterine Fibroids Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cooper Surgical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Richard Wolf Medical Instruments
2.4.1 Business Overview
2.4.2 Uterine Fibroids Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Richard Wolf Medical Instruments Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Blue Endo
2.5.1 Business Overview
2.5.2 Uterine Fibroids Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Blue Endo Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Boston Scientific Corporation
2.6.1 Business Overview
2.6.2 Uterine Fibroids Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boston Scientific Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Richard Wolf GmbH
2.7.1 Business Overview
2.7.2 Uterine Fibroids Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Richard Wolf GmbH Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Karl Storz
2.8.1 Business Overview
2.8.2 Uterine Fibroids Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Karl Storz Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Halt Medical, Inc.
2.9.1 Business Overview
2.9.2 Uterine Fibroids Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Halt Medical, Inc. Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Olympus Corporation
2.10.1 Business Overview
2.10.2 Uterine Fibroids Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Olympus Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Halt Medical, Inc.
2.11.1 Business Overview
2.11.2 Uterine Fibroids Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Halt Medical, Inc. Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Uterine Fibroids Treatment Market Competition, by Players
3.1 Global Uterine Fibroids Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Uterine Fibroids Treatment Players Market Share
3.2.2 Top 10 Uterine Fibroids Treatment Players Market Share
3.3 Market Competition Trend
4 Global Uterine Fibroids Treatment Market Size by Regions
4.1 Global Uterine Fibroids Treatment Revenue and Market Share by Regions
4.2 North America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
5 North America Uterine Fibroids Treatment Revenue by Countries
5.1 North America Uterine Fibroids Treatment Revenue by Countries (2014-2019)
5.2 USA Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
6 Europe Uterine Fibroids Treatment Revenue by Countries
6.1 Europe Uterine Fibroids Treatment Revenue by Countries (2014-2019)
6.2 Germany Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
6.4 France Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Uterine Fibroids Treatment Revenue by Countries
7.1 Asia-Pacific Uterine Fibroids Treatment Revenue by Countries (2014-2019)
7.2 China Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
7.5 India Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
8 South America Uterine Fibroids Treatment Revenue by Countries
8.1 South America Uterine Fibroids Treatment Revenue by Countries (2014-2019)
8.2 Brazil Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Uterine Fibroids Treatment by Countries
9.1 Middle East and Africa Uterine Fibroids Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
10 Global Uterine Fibroids Treatment Market Segment by Type
10.1 Global Uterine Fibroids Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Uterine Fibroids Treatment Market Forecast by Type (2019-2024)
10.3 Endometrial Ablation Revenue Growth Rate (2014-2024)
10.4 MRI Guided Procedures Revenue Growth Rate (2014-2024)
10.5 Hysterectomy Revenue Growth Rate (2014-2024)
10.6 Myomectomy Revenue Growth Rate (2014-2024)
10.7 Uterine Artery Embolization Revenue Growth Rate (2014-2024)
10.8 Radiofrequency Ablation Revenue Growth Rate (2014-2024)
10.9 Others Revenue Growth Rate (2014-2024)
11 Global Uterine Fibroids Treatment Market Segment by Application
11.1 Global Uterine Fibroids Treatment Revenue Market Share by Application (2014-2019)
11.2 Uterine Fibroids Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Ambulatory Surgical Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Uterine Fibroids Treatment Market Size Forecast (2019-2024)
12.1 Global Uterine Fibroids Treatment Market Size Forecast (2019-2024)
12.2 Global Uterine Fibroids Treatment Market Forecast by Regions (2019-2024)
12.3 North America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
12.6 South America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Uterine Fibroids Treatment Picture
Table Product Specifications of Uterine Fibroids Treatment
Table Global Uterine Fibroids Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Uterine Fibroids Treatment Revenue Market Share by Types in 2018
Figure Endometrial Ablation Picture
Figure MRI Guided Procedures Picture
Figure Hysterectomy Picture
Figure Myomectomy Picture
Figure Uterine Artery Embolization Picture
Figure Radiofrequency Ablation Picture
Figure Others Picture
Table Global Uterine Fibroids Treatment Revenue (Million USD) by Application (2014-2024)
Figure Uterine Fibroids Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market Uterine Fibroids Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table LiNA Medical Basic Information, Manufacturing Base and Competitors
Table LiNA Medical Uterine Fibroids Treatment Type and Applications
Table LiNA Medical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table Merit Medical Systems Uterine Fibroids Treatment Type and Applications
Table Merit Medical Systems Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cooper Surgical Basic Information, Manufacturing Base and Competitors
Table Cooper Surgical Uterine Fibroids Treatment Type and Applications
Table Cooper Surgical Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Richard Wolf Medical Instruments Basic Information, Manufacturing Base and Competitors
Table Richard Wolf Medical Instruments Uterine Fibroids Treatment Type and Applications
Table Richard Wolf Medical Instruments Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Blue Endo Basic Information, Manufacturing Base and Competitors
Table Blue Endo Uterine Fibroids Treatment Type and Applications
Table Blue Endo Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Uterine Fibroids Treatment Type and Applications
Table Boston Scientific Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Richard Wolf GmbH Basic Information, Manufacturing Base and Competitors
Table Richard Wolf GmbH Uterine Fibroids Treatment Type and Applications
Table Richard Wolf GmbH Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Karl Storz Basic Information, Manufacturing Base and Competitors
Table Karl Storz Uterine Fibroids Treatment Type and Applications
Table Karl Storz Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Halt Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table Halt Medical, Inc. Uterine Fibroids Treatment Type and Applications
Table Halt Medical, Inc. Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table Olympus Corporation Uterine Fibroids Treatment Type and Applications
Table Olympus Corporation Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Halt Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table Halt Medical, Inc. Uterine Fibroids Treatment Type and Applications
Table Halt Medical, Inc. Uterine Fibroids Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Uterine Fibroids Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Uterine Fibroids Treatment Revenue Share by Players (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Share by Players in 2017
Figure Global Uterine Fibroids Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Uterine Fibroids Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Uterine Fibroids Treatment Revenue Market Share in 2018
Figure Global Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Uterine Fibroids Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Uterine Fibroids Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Market Share by Regions in 2018
Figure North America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure South America Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table North America Uterine Fibroids Treatment Revenue by Countries (2014-2019)
Table North America Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Uterine Fibroids Treatment Revenue Market Share by Countries in 2018
Figure USA Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table Europe Uterine Fibroids Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Uterine Fibroids Treatment Revenue Market Share by Countries in 2018
Figure Germany Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure UK Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure France Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Uterine Fibroids Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Uterine Fibroids Treatment Revenue Market Share by Countries in 2018
Figure China Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure India Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table South America Uterine Fibroids Treatment Revenue by Countries (2014-2019)
Table South America Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Uterine Fibroids Treatment Revenue Market Share by Countries in 2018
Figure Brazil Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Uterine Fibroids Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Uterine Fibroids Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Uterine Fibroids Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Uterine Fibroids Treatment Revenue and Growth Rate (2014-2019)
Table Global Uterine Fibroids Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Uterine Fibroids Treatment Revenue Share by Type (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Share by Type (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Share by Type in 2018
Table Global Uterine Fibroids Treatment Revenue Forecast by Type (2019-2024)
Figure Global Uterine Fibroids Treatment Market Share Forecast by Type (2019-2024)
Figure Global Endometrial Ablation Revenue Growth Rate (2014-2019)
Figure Global MRI Guided Procedures Revenue Growth Rate (2014-2019)
Figure Global Hysterectomy Revenue Growth Rate (2014-2019)
Figure Global Myomectomy Revenue Growth Rate (2014-2019)
Figure Global Uterine Artery Embolization Revenue Growth Rate (2014-2019)
Figure Global Radiofrequency Ablation Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Uterine Fibroids Treatment Revenue by Application (2014-2019)
Table Global Uterine Fibroids Treatment Revenue Share by Application (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Share by Application (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue Share by Application in 2018
Table Global Uterine Fibroids Treatment Revenue Forecast by Application (2019-2024)
Figure Global Uterine Fibroids Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Uterine Fibroids Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Uterine Fibroids Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Uterine Fibroids Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
Figure Europe Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
Figure South America Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Uterine Fibroids Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界の子宮筋腫市場：市場規模・現状・予測

Global Uterine Fibroids Market Size, Status and Forecast 2019-2025
QYR9N8162 2019年6月14日 109Pages
当資料は、子宮筋腫のグローバル市場について調査・分析したレポートで、種類別（非ホルモン治療、ホルモン治療）、用途別（病院、外来手術センター、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の子宮肉腫の治療市場：市場規模・現状・予測

Global Uterine Sarcoma Treatment Market Size, Status and Forecast 2019-2025
QYR9N8163 2019年6月14日 95Pages
当資料は、子宮肉腫の治療のグローバル市場について調査・分析したレポートで、種類別（手術、放射線療法、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の子宮生検鉗子市場2019

Global Uterine Biopsy Forceps Sales Market Report 2019
QYR9N5400 2019年6月14日 102Pages
本調査レポートでは、子宮生検鉗子の世界市場について調査・分析し、子宮生検鉗子のメーカー別販売量、市場シェア分析、種類別販売分析（使い捨て子宮生検鉗子、再利用可能な子宮生検鉗子）、用途別販売分析（病院、診療所、外来手術センター）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格...

世界の子宮内避妊器具市場2019

Global Intra-Uterine Contraceptive Devices Sales Market Report 2019
QYR9N2025 2019年6月10日 120Pages
本調査レポートでは、子宮内避妊器具の世界市場について調査・分析し、子宮内避妊器具のメーカー別販売量、市場シェア分析、種類別販売分析（銅IUD、ホルモン性IUD）、用途別販売分析（病院、婦人科クリニック、地域医療）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向...

子宮マニピュレータ市場：世界及び中国市場分析・予測（～2024年）

Uterine manipulators Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J05548 2019年7月 148Pages
世界及び中国における子宮マニピュレータ市場について調査・分析したレポートで、子宮マニピュレータの世界市場動向、市場規模、主要企業情報などが含まれています。子宮マニピュレータの種類別には、子宮マニピュレータ、電動子宮ポジショナに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してま...

良性子宮疾患治療システム市場：世界及び中国の市場分析・予測（～2024年）

Benign Uterine Conditions Therapy Systems Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J08486 2019年7月 142Pages
世界及び中国における良性子宮疾患治療システム市場について調査・分析したレポートで、良性子宮疾患治療システムの世界市場動向、市場規模、主要企業情報などが含まれています。良性子宮疾患治療システムの種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。<...

女性用健康機器の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Women's Health Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C6440 2019年8月 101Pages
本調査レポートは、女性用健康機器の世界市場について調べ、まとめました。種類別セグメントは、機器、消耗品等、用途別セグメントは、癌、骨粗鬆症、感染症、子宮筋腫、閉経後症候群、妊娠、女性用殺菌、その他等に区分しました。女性用健康機器の世界市場概観、企業動向、企業別女性用健康機器シェア、市場規模推移、市場...

幹細胞脱毛症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Stem Cell Alopecia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5523 2019年7月 105Pages
本調査レポートは、幹細胞脱毛症治療の世界市場について調べ、まとめました。種類別セグメントは、円形脱毛症、全頭脱毛症、全身性脱毛症等、用途別セグメントは、等に区分しました。幹細胞脱毛症治療の世界市場概観、企業動向、企業別幹細胞脱毛症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要...

すくみ足治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Freezing of Gait Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2406 2019年7月 102Pages
本調査レポートは、すくみ足治療の世界市場について調べ、まとめました。種類別セグメントは、経口ドーパミン作動薬、ウェアラブルおよび歩行補助器具、深部脳刺激、その他等、用途別セグメントは、等に区分しました。すくみ足治療の世界市場概観、企業動向、企業別すくみ足治療シェア、市場規模推移、市場規模予測（201...

くる病治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Rickets Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4958 2019年7月 115Pages
本調査レポートは、くる病治療の世界市場について調べ、まとめました。種類別セグメントは、ビタミンDサプリメント、カルシウムサプリメント等、用途別セグメントは、等に区分しました。くる病治療の世界市場概観、企業動向、企業別くる病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析...

世界の子宮筋腫市場：市場規模・現状・予測 Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasional…
世界の子宮肉腫の治療市場：市場規模・現状・予測 Sarcomas are the tumours of the mesenchymal tissues like bone, muscle, connective tissue, cartilage and fat. Uterine sarcoma is a rare type of cancer which starts in the muscle and supporting tissues of the uterus. Exposure to the X-rays increases the risk for uterine sarcoma.In 2018, the global Ute…
世界の子宮生検鉗子市場2019 The global Uterine Biopsy Forceps market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Uterine Biopsy Forceps market status and forecast, categorizes the global Uterine Biopsy Forceps market size…
子宮マニピュレータ市場：世界及び中国市場分析・予測（～2024年） Uterine Manipulators Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Uterine Manipulators industry with a focus on the Chinese market. The report provides key statistics on the market status of the Uterine Manipulators manufac…
良性子宮疾患治療システム市場：世界及び中国の市場分析・予測（～2024年） Benign Uterine Conditions Therapy Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Benign Uterine Conditions Therapy Systems industry with a focus on the Chinese market. The report provides key statistics on the market …